Erythrocyte and Platelet Indices at Admission and Discharge Stratify Long-Term Cardiovascular Risk After Invasive Treatment of Myocardial Infarction
Authors:
- Christoph StrohhoferCSChristoph Strohhofer
- Faisal AzizFaisal Aziz
- Andreas KainzAKAndreas Kainz
- Andrea BergholdABAndrea Berghold
- Nicolas VerheyenNVNicolas Verheyen
- Heiko BuggerHBHeiko Bugger
- Stefan HatzlSHStefan Hatzl
- Raffaela PlankaRPRaffaela Planka
- Friederike von LewinskiFLFriederike von Lewinski
- Johannes GollmerJGJohannes Gollmer
- Klemens AblasserKAKlemens Ablasser
- Ivan VoskoIVIvan Vosko
Open Access
- 9 June 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4455
Abstract
Background/Objectives: Cardiovascular risk remains substantial after myocardial infarction (MI) despite established clinical risk markers. Erythrocyte and platelet indices are routinely available, but their long-term prognostic relevance remains insufficiently studied. Methods: This retrospective cohort study was based on the Styrian Registry on Genuine Myocardial Infarction (STRONG-MI) and included patients with MI undergoing invasive coronary angiography in Styria, Austria, between January 2007 and March 2016. Multivariable Cox regression models were used to assess the associations of admission and discharge erythrocyte and platelet indices with 3-point major adverse cardiovascular events (MACE) during follow-up extending to 175 months. Results: Among 10,920 patients, admission hemoglobin showed a U-shaped association with MACE. Median hemoglobin decreased from admission to discharge (14.2 g/dL vs. 13.1 g/dL) and the lowest discharge tertile showed the highest association with MACE compared with the middle tertile (AHR 1.27, 95% CI 1.18–1.38). Lower mean corpuscular hemoglobin concentration (MCHC) was independently linked to adverse outcomes at both admission and discharge (AHR 1.17, 95% CI 1.08–1.27, and 1.14, 95% CI 1.05–1.23, respectively). Higher platelet count and mean platelet volume (MPV) were also associated with increased risk, particularly at discharge (AHR 1.15, 95% CI 1.06–1.24, and 1.19, 95% CI 1.10–1.29, respectively). Conclusions: Routine erythrocyte and platelet indices were independently associated with long-term cardiovascular outcomes after invasively treated MI and reflect residual biological risk after discharge.Keywords
This publication has 25 references indexed in Scilit:
- Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and AnemiaNew England Journal of Medicine, 2023
- Impact of red blood cell distribution width and mean platelet volume in patients with ST-segment elevation myocardial infarctionHeart and Vessels, 2021
- Association between anemia and mortality in patients with acute coronary syndrome treated with percutaneous coronary intervention and contemporary lipid-lowering therapyHeart and Vessels, 2021
- Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and AnemiaJAMA, 2021
- Outcomes of anemic patients presenting with acute coronary syndrome: An analysis of the Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical EventsClinical Cardiology, 2019
- Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndromeEuropean Journal of Internal Medicine, 2019
- The link between anemia and adverse outcomes in patients with acute coronary syndromeExpert Review of Cardiovascular Therapy, 2018
- Baseline anemia in patients undergoing percutaneous coronary intervention after an acute coronary syndrome—A paradox of high bleeding risk, high ischemic risk, and complex coronary diseaseJournal of Interventional Cardiology, 2017
- Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary InterventionThe American Journal of Cardiology, 2016
- Anemia and mortality in acute coronary syndromes: A systematic review and meta-analysisAmerican Heart Journal, 2013